Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD

Jensen, D.; Amjadi, K.; Harris-McAllister, V.; Webb, K. A.; O'Donnell, D. E.
July 2008
Thorax;Jul2008, Vol. 63 Issue 7, p606
Academic Journal
Background: This study examined the effects of inhaled furosemide on the ventilatory and perceptual response to high-intensity constant-load cycle exercise in chronic obstructive pulmonary disease (COPD). Methods: In a randomised, double-blind, placebo-controlled, crossover study, 20 patients with COPD (mean (SD) forced expiratory volume in 1 s 45 (15)% predicted) received either nebulised furosemide 40 mg or placebo on two separate days. Thirty minutes after each treatment, patients performed pulmonary function tests and a symptom-limited cycle exercise test at 75% of their maximum incremental work rate. Changes in spirometry, plethysmographic lung volumes, dynamic operating lung volumes, ventilation, breathing pattern, cardiovascular function, dyspnoea intensity and exercise endurance time were compared between treatments. Results: Compared with placebo, treatment with furosemide resulted in a mean (SD) decrease in dyspnoea intensity at the highest equivalent exercise time (ie, isotime for each patient) of 0.9 (1.0) Borg units (p<0.01) and an increase in exercise endurance time of 1.65 (0.63) mm )p'<0.05). These improvements were associated with increases in dynamic inspiratory capacity, tidal volume and mean tidal expiratory flow rates at isotime (p<0.01). The eight patients whose exercise endurance time improved by >1 mm had greater changes in operating lung volumes (p<0.05), submaximal oxygen pulse (p<0.05) and oxygen uptake (p = 0.05) than those in whom exercise endurance time did not improve. Conclusion: Alleviation of exertional dyspnoea after single-dose furosemide inhalation in COPD is multifactorial but improvements in dynamic ventilatory mechanics are contributory in some individuals.


Related Articles

  • Education: Red flag symptoms - Breathlessness. Jacobi, Tillmann // GP: General Practitioner;7/7/2014, p37 

    The article discusses breathlessness as a harmless symptom and as an indicator of a serious condition. Topics covered include the possible illnesses related to severe acute or prolonged breathlessness, the importance of a calm and decisive approach in handling breathlessness, and the steps for...

  • Dyspnea: COPD or heart failure? Pinkowish, Mary Desmond; Amsterdam, Ezra A.; Morrissey, Brian // Patient Care;Jun2002, Vol. 36 Issue 8, p12 

    Describes the most effective means of determining whether chronic obstructive pulmonary disease or congestive heart failure is the cause of the breathlessness of a patient with increasing dyspnea. History and physical examination; Testing; Beta-naturetic protein determination. INSET: What...

  • A 6-Year-Old Girl With Progressive Dyspnea. Yang, David T.; Zhou, Holly; Jaffe, Richard B. // Archives of Pathology & Laboratory Medicine;Sep2003, Vol. 127 Issue 9, p393 

    Presents the medical case of a girl with progressive dyspnea. Results of physical examination; Finding on gross examination of the lungs; Primary pathologic change in pulmonary veno-occlusive disease (PVOD); Prognosis for patients with PVOD.

  • Evaluation of Chronic Dyspnea. Karnani, Neel G.; Reisfield, Gary M.; Wilson, George R. // American Family Physician;4/15/2005, Vol. 71 Issue 8, p1529 

    Chronic dyspnea is defined as dyspnea lasting more than one month. In approximately two thirds of patients presenting with dyspnea, the underlying cause is cardiopulmonary disease. Establishing an accurate diagnosis is essential because treatment differs depending on the underlying condition....

  • Pulmonary and Ophthalmic Involvement With Erdheim-Chester Disease. Allen, Timothy Craig; Gievez-Barrios, Patricia; Shetlar, Debra J.; Cagle, Philip T. // Archives of Pathology & Laboratory Medicine;Dec2004, Vol. 128 Issue 12, p1428 

    Erdheim-Chester disease is a rare nonfamilial histiocytic disorder of unknown etiology with characteristic long bone findings. The 3-year survival rate for patients with Erdheim-Chester disease is 50%. Approximately 50% of patients have disease involvement in other tissues, including skin,...

  • Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Vestbo, J.; Pauwels, R.; Anderson, J. A.; Jones, P.; Calverley, P. // Thorax;Apr2005, Vol. 60 Issue 4, p301 

    Background: Combined treatment with inhaled corticosteroids and long acting β2 agonists is approved for the treatment of chronic obstructive pulmonary disease (COPD), but little is known about the onset of effect of the combination. Methods: Data were used from 1465 patients with COPD entered...

  • Reversible restrictive lung disease stimulating asthma. Hudgel, David W.; Cooper, David; Souhrada, Joseph; Hudgel, D W; Cooper, D; Souhrada, J // Annals of Internal Medicine;Sep76, Vol. 85 Issue 3, p328 

    A young adult woman presented with spontaneous and exercise-induced episodic dyspnea without wheezing. During dyspneic episodes all static lung volumes decreased markedly, the inspiratory capacity fell from 3.0 to 1.1 litres and total lung capacity from 5.3 to 2.6 litres. Airway resistance (Raw)...

  • Dyspnea affective response: comparing COPD patients with healthy volunteers and laboratory model with activities of daily living. O'Donnell, Carl R.; Schwartzstein, Richard M.; Lansing, Robert W.; Guilfoyle, Tegan; Elkin, Daniel; Banzett, Robert B. // BMC Pulmonary Medicine;2013, Vol. 13 Issue 1, p1 

    Background: Laboratory-induced dyspnea (breathing discomfort) in healthy subjects is widely used to study perceptual mechanisms, yet the relationship between laboratory-induced dyspnea in healthy volunteers and spontaneous dyspnea in patients with chronic lung disease is not well established. We...

  • Worsening breathlessness in a patient with congestive cardiac failure. Lakasing, Edin; Tester, Melanie // Primary Health Care;Mar2008, Vol. 18 Issue 2, p38 

    A case study of an 86-year old man with worsening dyspnoea is presented. The patient had suffered relatively stable breathlessness for six years. Several issues relating to the assessment and diagnosis of chronic obstructive pulmonary disease (COPD) in nurse-led clinic are illustrated. In...


Read the Article


Sign out of this library

Other Topics